Cargando…

Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation

BACKGROUND: Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Nevertheless, whether abnormalities of T cell subsets in the bone marrow (BM) immune microenvironment, including Th17, Tc17, Th1, Tc1, Th2, Tc2 cells and reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Yuan, Wang, Yu-Tong, Cao, Xie-Na, Song, Yang, Chen, Yu-Hong, Sun, Yu-Qian, Wang, Yu, Zhang, Xiao-Hui, Xu, Lan-Ping, Huang, Xiao-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351211/ https://www.ncbi.nlm.nih.gov/pubmed/28292332 http://dx.doi.org/10.1186/s12967-017-1159-y

Ejemplares similares

Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
por: Xiao, Yang, et al.
Publicado: (2014)

Optimizing allogeneic grafts in hematopoietic stem cell transplantation
por: Xu, Zheng‐Li, et al.
Publicado: (2021)

Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation
por: Chen, Juan, et al.
Publicado: (2020)

Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
por: Tang, Cen, et al.
Publicado: (2018)

Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
por: Szyska, Martin, et al.
Publicado: (2016)

Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
por: Master, Samip, et al.
Publicado: (2018)

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

Immune Reconstitution and Graft-Versus-Host Reactions in Rat Models of Allogeneic Hematopoietic Cell Transplantation
por: Zinöcker, Severin, et al.
Publicado: (2012)

Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Liu, Jing, et al.
Publicado: (2018)

Treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: the role of corticosteroids
por: Mo, Xiao-Dong, et al.
Publicado: (2018)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
por: Krüger, Thomas, et al.
Publicado: (2022)

P1533: A PROGNOSTIC MODEL FOR PATIENTS WITH SEPTIC SHOCK AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Huang, Qiu-Sha, et al.
Publicado: (2023)

P1297: CLINICAL PROGNOSTIC MODEL OF OSTEONECROSIS OF THE FEMORAL HEAD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Yang, Bo, et al.
Publicado: (2023)

Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of Tunisia
por: Achour, Leila, et al.
Publicado: (2023)

Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2017)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
por: Tian, Linlu, et al.
Publicado: (2022)

Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation
por: Zhou, Jing-Rui, et al.
Publicado: (2021)

Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation
por: Masouridi-Levrat, Stavroula, et al.
Publicado: (2016)

DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation
por: Trino, Stefania, et al.
Publicado: (2019)

The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation
por: Peci, Flavia, et al.
Publicado: (2022)

Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
por: Servais, Sophie, et al.
Publicado: (2023)

Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants
por: Kong, Yuan, et al.
Publicado: (2016)

Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation
por: Lv, Meng, et al.
Publicado: (2013)

Dendritic Cells Are Critical for the Activation and Expansion of Vδ2(+) T Cells After Allogeneic Hematopoietic Transplantation
por: Wang, Xiaoyu, et al.
Publicado: (2018)

Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantation
por: Gao, Meng-Ge, et al.
Publicado: (2020)

S290: DEVELOPMENT AND VALIDATION OF A PROGNOSTIC MODEL OF BRONCHIOLITIS OBLITERANS SYNDROME IN ADULT PATIENTS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Huang, Qiu-Sha, et al.
Publicado: (2023)

Correction: Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2018)

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
por: Tijaro-Ovalle, Natalia M., et al.
Publicado: (2019)

γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation
por: Wu, Ning, et al.
Publicado: (2021)

Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
por: Simonetta, Federico, et al.
Publicado: (2017)

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
por: Niu, Chang-He, et al.
Publicado: (2020)

Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
por: Olsson, Richard F., et al.
Publicado: (2015)

Lung Transplantation for Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kim, Yu Ri, et al.
Publicado: (2012)

Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
por: Zhao, Xiao-su, et al.
Publicado: (2014)

Exosomes Released From Human Bone Marrow–Derived Mesenchymal Stem Cell Attenuate Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Mice
por: Li, Ke-Liang, et al.
Publicado: (2021)

Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation
por: Man, Yan, et al.
Publicado: (2022)

Immune reconstitution and survival of patients after allogeneic hematopoietic stem cell transplantation from older donors
por: Jiang, Peiyao, et al.
Publicado: (2022)

Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis
por: Woodard, P, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_bn6434eaau9nrabdl4k4uatlv5